Literature DB >> 8549179

The etiology of pleural effusions in an area with high incidence of tuberculosis.

L Valdés1, D Alvarez, J M Valle, A Pose, E San José.   

Abstract

To investigate the etiology of pleural effusions in our region, we undertook a prospective study of patients with this condition in our centers. During a 5-year period, we studied 642 pleural effusion patients aged 57.1 +/- 21.1 years, of whom 401 were men aged 56.5 +/- 21 years and 241 were women aged 57.8 +/- 21.4 years; the male/female ratio was 1.6:1. The most frequent cause of pleural effusion was tuberculosis (25%), followed by neoplasia (22.9%) and congestive heart failure (17.9%). The etiology of 48 cases (7.5%) remained uncertain. In the neoplastic effusion group, the most frequent locations of the primary tumor were lung (32.6%), breast (11.5%), lymphoma (10.8%), and ovary (7.5%); in 21 cases (14.3% of the neoplastic group), it was not possible to identify the primary tumor. The 111 patients aged younger than 40 years with tuberculous effusions made up 69.4% of tuberculous effusion cases and the same percentage of patients younger than 40 years; the proportion of effusions that were tuberculous peaked in the 11- to 30-year-old age group and declined steadily thereafter. Of the patients with neoplastic effusions, 83% were older than 50 years; the proportion of effusions that were neoplastic rose steadily from zero in the 0- to 30-year-old age group to a peak among 60- to 70-year-olds. The age-wise distribution of effusions secondary to congestive heart failure was similar to that of neoplastic effusions. Of the effusions secondary to congestive heart failure, 86% (99/115) affected the right pleura or both, and 83% of effusions secondary to pulmonary thromboembolism (15/18) affected the right side. Neoplastic, tuberculous, parapneumonic, empyematous, and other exudative effusions showed no preference for either side. Of the 97 bilateral effusions, 77 (79.4%) were secondary to heart failure (59, 60.8%) or neoplasia (18, 18.6%). We conclude that in our region, the most frequent cause of pleural effusion is tuberculosis, followed by neoplasia and congestive heart failure. We suggest that all those interested in pleural disease should determine the etiologic pattern of pleural effusion in their region with a view to the adoption of regionally optimized diagnostic and therapeutic attitudes.

Entities:  

Mesh:

Year:  1996        PMID: 8549179     DOI: 10.1378/chest.109.1.158

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  37 in total

1.  Usefulness of triglyceride levels in pleural fluid.

Authors:  Luis Valdés; Maria Esther San José; Antonio Pose; Juan Carlos Estévez; Francisco J González-Barcala; José M Alvarez-Dobaño; Richard W Light
Journal:  Lung       Date:  2010-10-05       Impact factor: 2.584

2.  Single pleural relapse of a nasal-type extranodal natural killer/t-cell lymphoma: a case report.

Authors:  Keunmo Kim; Youngmin Oh; Sung-Nam Lim; Song-Yi Choi; Ok-Jun Lee; Kang-Hyeon Choe; Ki-Man Lee; Jin-Young An
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25

3.  Role of medical thoracoscopy in the treatment of tuberculous pleural effusion.

Authors:  Yu Xiong; Xusheng Gao; Huaiyang Zhu; Caihong Ding; Jian Wang
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

4.  Sonographic evaluation of unexplained pleural exudate: a prospective case series.

Authors:  Robert Marcun; Alan Sustic
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Comparison of MGIT and Myco/F lytic liquid-based blood culture systems for recovery of Mycobacterium tuberculosis from pleural fluid.

Authors:  Elizabeth Harausz; John Kafuluma Lusiba; Mary Nsereko; John L Johnson; Zahra Toossi; Sam Ogwang; W Henry Boom; Moses L Joloba
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

6.  Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.

Authors:  Luis Corral-Gudino; Alberto García-Zamalloa; Cristina Prada-González; Silvia Bielsa; Duckens Alexis; Jorge Taboada-Gómez; Pilar R Dos-Santos-Gallego; María A Alonso-Fernández; Jose M Porcel
Journal:  Lung       Date:  2016-07-11       Impact factor: 2.584

Review 7.  Tuberculous pleural effusion.

Authors:  Kan Zhai; Yong Lu; Huan-Zhong Shi
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

8.  Role of blind closed pleural biopsy in the managment of pleural exudates.

Authors:  Marco F Pereyra; Esther San-José; Lucía Ferreiro; Antonio Golpe; José Antúnez; Francisco-Javier González-Barcala; Ihab Abdulkader; José M Álvarez-Dobaño; Nuria Rodríguez-Núñez; Luis Valdés
Journal:  Can Respir J       Date:  2013-08-15       Impact factor: 2.409

9.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

10.  Role of common investigations in aetiological evaluation of exudative pleural effusions.

Authors:  Arnab Maji; Malay Kumar Maikap; Debraj Jash; Kaushik Saha; Abhijit Kundu; Debabrata Saha; Sourindranath Banerjee; Anupam Patra
Journal:  J Clin Diagn Res       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.